TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

ASTCT’s Transplant Infectious Disease (ID) Special Interest Group (SIG) has curated a track of sessions at this year’s Tandem Meetings. Sessions center around the latest in protecting...

In his last message as ASTCT President, David Porter, MD, highlights how his successes in 2025 were a shared effort, made possible by the ASTCT Board, staff, and members. He reflects on key...

This member spotlight features ex-officio ASTCT Board member Dr. Robert Korngold Ph.D., editor-in-chief for the Transplantation and Cellular Therapy journal. Korngold, a retired research scientist...

In a special cobranded episode between Oncology On the Go and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks, Rahul Banerjee, MD, FACP, a...

The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid tumor treatment. Certain characteristics seen in solid tumors...

In this episode of ASTCT Talks, supported by an educational grant from Sanofi US, host Dr. Corey Cutler, MD, from Dana-Farber Cancer Institute, sits down with Dr. Sanjeet Singh Dadwal, MD, chief...